Oncimmune (LON:ONC) Shares Down 4.2% – Here’s Why

Oncimmune Holdings plc (LON:ONC) shares fell 4.2% during trading on Monday . The stock traded as low as GBX 14.85 ($0.19) and last traded at GBX 14.85 ($0.19). 210,591 shares changed hands during trading, an increase of 72% from the average session volume of 122,679 shares. The stock had previously closed at GBX 15.50 ($0.20).

Oncimmune Price Performance

The company’s fifty day moving average price is GBX 16.49 and its 200 day moving average price is GBX 16.22. The company has a market capitalization of £11.20 million, a P/E ratio of -505.00 and a beta of 1.19. The company has a quick ratio of 0.63, a current ratio of 1.13 and a debt-to-equity ratio of 806.85.

Oncimmune Company Profile

Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.